Back to search

Ketotifen effectively prevents mucosal damage in experimental colitis.

Data up to Jan 2025

Published1992
Citations80
References29

Total Citations Per Year

Abstract

References (29)

Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker

1982 • 3,566 citations

Hapten-Induced Model of Chronic Inflammation and Ulceration in the Rat Colon

1989 • 1,681 citations

Enhanced Synthesis of Leukotriene B4 by Colonic Mucosa in Inflammatory Bowel Disease

1984 • 749 citations

Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease

1989 • 433 citations

Recent Developments in Nonspecific Inflammatory Bowel Disease

1982 • 341 citations

Inflammatory mediators of experimental colitis in rats

1989 • 264 citations

Metabolism of Arachidonic Acid in Acetic Acid Colitis in Rats

1985 • 259 citations

Role of platelet-activating factor in ulcerative colitis

1988 • 198 citations

Recent Developments in Nonspecific Inflammatory Bowel Disease

1982 • 195 citations

Alterations of the Immune System in Ulcerative Colitis and Crohn's Disease

1988 • 160 citations

Radioimmunological assay of prostaglandin synthetase activity

1973 • 149 citations

Treatment With 16, 16'-Dimethyl Prostaglandin E2 Before and After Induction of Colitis With Trinitrobenzenesulfonic Acid in Rats Decreases Inflammation

1989 • 130 citations

THE ROLE OF THE MUCOSAL IMMUNE SYSTEM IN INFLAMMATORY BOWEL DISEASE

1992 • 127 citations

The jejunal secretion of histamine is increased in active Crohn's disease

1990 • 122 citations

Enhancement of human intestinal mast cell mediator release in active ulcerative colitis

1990 • 117 citations

Gastric Mucosal Damage by Ethanol Is Mediated by Substance P and Prevented by Ketotifen, a Mast Cell Stabilizer

1991 • 105 citations

Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis

1987 • 79 citations

Release of platelet-activating factor (PAF) and accelerated healing induced by a PAF antagonist in an animal model of chronic colitis

1988 • 77 citations

Assessment of the role of platelet-activating factor in an animal model of inflammatory bowel disease.

1989 • 59 citations

The Pharmacology of Ketotifen

1982 • 51 citations

The effect of leukotriene-B4 receptor antagonist, SC-41930, on acetic acid-induced colonic inflammation

1989 • 48 citations

Mast cell polymorphisms

1988 • 41 citations

Histamine content of rectal mucosa in ulcerative colitis.

1967 • 34 citations

Mediators release and function

1984 • 33 citations

Mast cells as a component of the granuloma in crohn's disease

1973 • 33 citations

Ketotifen treatment of atopic dermatitis and other food allergy diseases

1989 • 10 citations

Ketotifen treatment of atopic dermatitis and other food allergy diseases

1989 • 10 citations

Mast cells and basophils: models for studying the antianaphylactic potency of drugs.

1983 • 4 citations

The effect of ketotifen on the in vitro immune function of asthmatic children.

1983 • 3 citations

Cited By (0)

Loading...
Ketotifen effectively prevents mucosal damage in experimental colitis. (1992) – Gut | Metascience Observatory Explorer